Why Dynatrace, Revance Therapeutics, and Immunomedics Slumped Today
Wednesday brought some holiday cheer to Wall Street, as investors got out of the gloomy mood on hopes that their initial fears about a prolonged trade war between the U.S. and China might prove to have been overblown. Some reports suggested that the two nations might be closer to an early deal than previously thought, and cyclically sensitive markets like energy and bonds responded accordingly. However, several companies took the opportunity to raise capital by selling shares, sending their stock prices lower. Dynatrace (NYSE:DT), Revance Therapeutics (NASDAQ:RVNC), and Immunomedics (NASDAQ:IMMU) were among ...